CLINICAL FEATURES OF PATIENT WITH SEVERE ACQUIRED ADAMTS13 DEFICIENCY IN THROMBOTIC THROMBOCYTOPENIC PURPURA

被引：0
|
作者：
Oh, D. [1 ]
Kim, I. -H. [2 ]
Jung, C. -W. [3 ]
Le, J-W. [4 ]
Lee, H. G. [5 ]
Sohn, S. K. [6 ]
机构：
[1] CHA Univ, Internal Med, Songnam, South Korea
[2] Seoul Natl Univ, Coll Med, Internal Med, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Internal Med, Seoul, South Korea
[4] Catholic Univ, Coll Med, Internal Med, Seoul, South Korea
[5] Konkuk Univ, Sch Med, Internal Med, Seoul, South Korea
[6] Kyungpook Natl Univ, Internal Med, Daegu, South Korea
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1407
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [31] Application of PLASMIC score in prediction of ADAMTS13 deficiency in a pediatric case of acquired thrombotic thrombocytopenic purpura
    Gupta, Gaurav K.
    Hendrickson, Jeanne E.
    Tormey, Christopher A.
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (02) : 140 - 141
  • [32] Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
    Lorenz, Judith
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2024, 228 (05): : 410 - 411
  • [33] ADAMTS13 Deficiency and Thrombotic Thrombocytopenic Purpura Associated with Trimethoprim-Sulfamethoxazole
    Bapani, Sowjanya
    Epperla, Narendranath
    Kasirye, Yusuf
    Mercier, Richard
    Garcia-Montilla, Romel
    CLINICAL MEDICINE & RESEARCH, 2013, 11 (02) : 86 - 90
  • [34] Thrombotic Thrombocytopenic Purpura: Relationship of Infection and ADAMTS13
    Watanaboonyongcharoen, P.
    Brecher, M. E.
    Schultz, E. F.
    Hay, S. N.
    Park, Y. A.
    TRANSFUSION, 2012, 52 : 126A - 127A
  • [35] Recombinant ADAMTS13 for Hereditary Thrombotic Thrombocytopenic Purpura
    Asmis, Lars M. M.
    Serra, Andreas
    Krafft, Alexander
    Licht, Abraham
    Leisinger, Elke
    Henschkowski-Serra, Jana
    Ganter, Michael T. T.
    Hauptmann, Steffen
    Tinguely, Marianne
    Hovinga, Johanna A. Kremer A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (25): : 2356 - 2361
  • [36] Targeting the inhibitor of ADAMTS13 in thrombotic thrombocytopenic purpura
    Cataland, Spero R.
    Wu, Haifeng M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (04) : 437 - 444
  • [37] Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura
    Scully, Marie
    Antun, Ana
    Cataland, Spero R.
    Coppo, Paul
    Dossier, Claire
    Biebuyck, Nathalie
    Hassenpflug, Wolf-Achim
    Kentouche, Karim
    Knoebl, Paul
    Kremer Hovinga, Johanna A.
    Lopez-Fernandez, M. Fernanda
    Matsumoto, Masanori
    Ortel, Thomas L.
    Windyga, Jerzy
    Bhattacharya, Indranil
    Cronin, Michael
    Li, Hong
    Mellgard, Bjorn
    Patel, Munjal
    Patwari, Parth
    Xiao, Shan
    Zhang, Pinghai
    Wang, Linda T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (17): : 1584 - 1596
  • [38] Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura
    Zheng, X. Long
    Wu, Haifeng M.
    Shang, Dezhi
    Falls, Erica
    Skipwith, Christopher G.
    Cataland, Spero R.
    Bennett, Charles L.
    Kwaan, Hau C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (09): : 1555 - 1562
  • [39] Evaluating the impact of the ABO blood group on the clinical outcome of thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency
    Hussein, E.
    Teruya, J.
    VOX SANGUINIS, 2017, 112 (05) : 434 - 442
  • [40] Diagnostic Challenges in a Case of Immune-Mediated Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency
    Escoto-Pineda, Karel
    Alas-Pineda, Cesar
    Pavon-Varela, Dennis Javier
    Cortes, David
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
12345